# 2026-13373: FDA Ends Emergency Use for COVID Medical Devices

2026-13373, Termination of Three Declarations Authorizing Emergency Use of Medical Devices During the COVID-19 Pandemic, is a Federal Register notice from Health and Human Services Department published 2026-07-02, effective 2026-12-26; PRIA reads it as touching household money (as of 2026-07-09).

- Canonical: https://policyrisk.com/federal-register/2026-13373
- As of: 2026-07-09
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-13373
- Title: Termination of Three Declarations Authorizing Emergency Use of Medical Devices During the COVID-19 Pandemic
- Type: Notice
- Agencies: Health and Human Services Department
- Citation: 91 FR 40544
- Published: 2026-07-02
- Effective: 2026-12-26
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-07-09

## In one line

FDA Ends Emergency Use for COVID Medical Devices

## Summary

The U.S. Department of Health and Human Services is ending the emergency use authorizations for certain COVID-19 medical devices, including tests and masks, on December 26, 2026. This change affects manufacturers, healthcare providers, and anyone using these devices, signaling a return to normal rules and regulations. No emergency use means these products will now follow regular approval processes, with no extra emergency funding involved.

## Abstract

The Secretary of Health and Human Services (HHS) is issuing this notice pursuant to section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C) Act. On February 4, 2020, as amended on March 15, 2023, HHS determined that there is a public health emergency, or significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad, and that involves the virus (later referred to as SARS-CoV-2) that causes COVID-19. On the basis of this determination, the HHS Secretary declared that circumstances exist justifying the authorization of emergency use of (1) in vitro diagnostics for detection and/or diagnosis of SARS-CoV-2 (February 4, 2020); (2) personal respiratory protective devices during the COVID-19 outbreak (March 2, 2020); and (3) medical devices, including alternative products used as medical devices (March 24, 2020). On June 29, 2026, the HHS Secretary determined that circumstances no longer exist justifying the authorization of emergency use of these medical devices. On the basis of this determination, the HHS Secretary is terminating these declarations ("EUA declarations"), effective on December 26, 2026.

## Effects PRIA read

- EUA Termination for COVID-19 Devices: mixed, low. The Department of Health and Human Services is terminating three emergency-use declarations for (1) in vitro diagnostic COVID-19 tests, (2) personal respiratory protective devices (masks), and (3) certain medical devices on December 26, 2026. This affects manufacturers, healthcare providers, and an…
- Manufacturers Must Seek Regular Approval: cost, medium. FDA and HHS are encouraging manufacturers of EUA-authorized COVID-19 tests, personal respiratory protective devices, and other medical devices to obtain authorization through traditional premarket/marketing pathways and to begin transition planning. FDA issued final guidance in March 2023 and HHS i…
- No Emergency Funding; Product Disposition Rules: cost, low. HHS states there will be no extra emergency funding tied to these EUAs and that, if an EUA ceases to be effective, HHS/FDA will consult with manufacturers about appropriate disposition or return of unapproved products. The notice also functions as the required 180-day advance notice before the Dece…

## Related documents

- [2026-22812](https://policyrisk.com/federal-register/2026-22812): Medicare and Medicaid Programs; Cutting Administrative Requirements for Excellence in Patient Care, 2026-11-10
- [2026-22792](https://policyrisk.com/federal-register/2026-22792): Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program, 2026-11-09
- [2026-22750](https://policyrisk.com/federal-register/2026-22750): Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the E…, 2026-11-09
- [2026-22743](https://policyrisk.com/federal-register/2026-22743): Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage…, 2026-11-09
- [2026-22739](https://policyrisk.com/federal-register/2026-22739): Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; i…, 2026-11-06
- [2026-22381](https://policyrisk.com/federal-register/2026-22381): Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage, 2026-11-03

## Sources
- [2026-13373 on federalregister.gov](https://www.federalregister.gov/documents/2026/07/02/2026-13373/termination-of-three-declarations-authorizing-emergency-use-of-medical-devices-during-the-covid-19)
- [2026-13373 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-07-02/pdf/2026-13373.pdf)

## Related
- [Previous: 2026-13369, Submission for Office of Management and Budget Review; Office of Refugee Resett…](https://policyrisk.com/federal-register/2026-13369)
- [Next: 2026-13374, Termination of Declaration Authorizing Emergency Use of Drug and Biological Pro…](https://policyrisk.com/federal-register/2026-13374)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-13373 (as of 2026-07-09).
